Lavipharm S.A. (ATH:LAVI)
Greece · Delayed Price · Currency is EUR 1.540
-0.006 (-0.39%)
Jun 11, 2026, 3:24 PM EET
Lavipharm Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.99 | 8.98 | 1.87 | 0.83 | 1.72 |
Depreciation & Amortization | 5.09 | 4.58 | 4.21 | 1.5 | 1.43 |
Other Amortization | 0.13 | - | - | 0.21 | 0.22 |
Loss (Gain) From Sale of Assets | -0.73 | - | -0.41 | 0 | -0.04 |
Asset Writedown & Restructuring Costs | -0.04 | -0.16 | -0.37 | - | -0.11 |
Loss (Gain) From Sale of Investments | - | - | -0.09 | 0.18 | 0.05 |
Provision & Write-off of Bad Debts | -0.01 | -0.32 | - | -0.37 | 0.63 |
Other Operating Activities | 2.12 | -2.85 | 2.01 | 4.47 | 3.26 |
Change in Accounts Receivable | -5.71 | -1.28 | -6.23 | -0.08 | -3.39 |
Change in Inventory | -2.86 | -5.34 | -4.94 | -1.94 | -0.75 |
Change in Accounts Payable | 2.76 | 0.14 | 2.65 | -1.52 | 1.04 |
Change in Other Net Operating Assets | -0.01 | -0.01 | 0.04 | 0.18 | 0.05 |
Operating Cash Flow | 6.66 | 4.5 | 0.28 | 3.35 | 4.11 |
Operating Cash Flow Growth | 48.13% | 1483.80% | -91.51% | -18.57% | 44.17% |
Capital Expenditures | -1.27 | -9.64 | -4.05 | -35.62 | -1.92 |
Sale of Property, Plant & Equipment | 0.12 | - | 0.41 | 0 | 0.01 |
Sale (Purchase) of Intangibles | -3.35 | - | - | - | - |
Sale (Purchase) of Real Estate | 2.1 | - | - | - | - |
Other Investing Activities | 1.46 | 0.14 | 0.19 | 0.02 | 0.02 |
Investing Cash Flow | -0.94 | -9.5 | -3.46 | -35.59 | -1.88 |
Long-Term Debt Issued | 41.84 | 35.22 | 49.68 | 25.18 | 14.77 |
Long-Term Debt Repaid | -43.6 | -32.41 | -54.41 | -25.62 | -17.29 |
Net Debt Issued (Repaid) | -1.77 | 2.82 | -4.73 | -0.44 | -2.52 |
Issuance of Common Stock | - | - | - | 49.29 | - |
Repurchase of Common Stock | -0.2 | - | - | - | - |
Common Dividends Paid | -3.38 | - | - | - | - |
Other Financing Activities | -0 | -0.66 | -1.91 | - | - |
Financing Cash Flow | -5.35 | 2.16 | -6.63 | 48.85 | -2.52 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - |
Net Cash Flow | 0.38 | -2.85 | -9.81 | 16.6 | -0.29 |
Free Cash Flow | 5.39 | -5.15 | -3.77 | -32.27 | 2.19 |
Free Cash Flow Growth | - | - | - | - | 59.53% |
Free Cash Flow Margin | 8.62% | -9.72% | -7.87% | -82.63% | 5.52% |
Free Cash Flow Per Share | 0.03 | -0.03 | -0.02 | -1.50 | 0.13 |
Cash Interest Paid | 1.8 | 1.93 | 1.93 | 1.54 | 1.82 |
Cash Income Tax Paid | 0.41 | 0.17 | 0.26 | 0.04 | 0.06 |
Levered Free Cash Flow | 1.64 | -4.84 | -4.59 | -30.36 | 2.62 |
Unlevered Free Cash Flow | 2.79 | -3.59 | -3.24 | -29.91 | 3.76 |
Change in Working Capital | -5.82 | -6.49 | -8.48 | -3.36 | -3.06 |